Disc Medicine Inc (IRON)

Oct 31, 2025

Morgan Stanley Issues Positive Forecast for Disc Medicine (NASDAQ:IRON) Stock Price - MarketBeat

Oct 31, 2025

Oct 31, 2025

Disc Medicine stock reiterated Strong Buy at Raymond James on DISC-0974 potential - Investing.com

Oct 31, 2025

Oct 31, 2025

Analysts Conflicted on These Healthcare Names: Kyverna Therapeutics, Inc. (KYTX), Disc Medicine (IRON) and Baxter International (BAX) - The Globe and Mail

Oct 31, 2025

Oct 31, 2025

Disc Medicine to Participate in Upcoming Investor Conferences - Enidnews.com

Oct 31, 2025

Oct 31, 2025

Disc Medicine (NASDAQ: IRON) to appear at Guggenheim, Stifel, Jefferies; live webcasts - Stock Titan

Oct 31, 2025

Oct 31, 2025

Is Disc Medicine Inc. stock trading near support levelsJuly 2025 Update & Weekly Stock Breakout Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Can Disc Medicine Inc. stock weather global recession2025 Earnings Impact & Weekly High Momentum Picks - newser.com

Oct 31, 2025

Oct 31, 2025

Is Disc Medicine Inc. stock in correction or buying zone2025 Technical Overview & Risk Controlled Swing Trade Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Why Disc Medicine Inc. stock is considered a top pick2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com

Oct 31, 2025

Oct 31, 2025

Will Disc Medicine Inc. stock maintain growth storyQuarterly Market Summary & Community Consensus Trade Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Disc Medicine, Inc. (NASDAQ:IRON) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 31, 2025

Oct 31, 2025

What valuation multiples suggest for Disc Medicine Inc. stockEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com

Oct 31, 2025

Oct 31, 2025

Applying Wyckoff theory to Disc Medicine Inc. stock2025 Sector Review & Stock Portfolio Risk Control - newser.com

Oct 31, 2025

Oct 30, 2025

WilmerHale Advises Underwriters in $287.5 Million Public Offering of Disc Medicine - WilmerHale

Oct 30, 2025

Oct 30, 2025

IRON Stock: Morgan Stanley Raises Price Target to $115 | IRON St - GuruFocus

Oct 30, 2025

Oct 30, 2025

Morgan Stanley Raises Price Target on Disc Medicine to $115 From $90, Keeps Overweight Rating - MarketScreener

Oct 30, 2025

Oct 30, 2025

Disc Medicine’s Promising Anemia Treatment Study: Key Insights for Investors - MSN

Oct 30, 2025

Oct 29, 2025

Chronic Kidney Disease Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Jiangsu HengRui, Disc Medicine, 3SBio, Kind Pharma, Jiangsu Hansoh Pharm - Barchart.com

Oct 29, 2025

Oct 29, 2025

Disc Medicine (IRON): Evaluating Valuation After New Clinical Trial Plans and FDA Recognition Boost Pipeline Momentum - Yahoo Finance

Oct 29, 2025

Oct 28, 2025

Disc Medicine planning trial of iron overload treatment for sickle cell - Sickle Cell Disease News

Oct 28, 2025

Oct 28, 2025

Aug Chart Watch: Why Disc Medicine Inc. stock is considered a top pickQuarterly Earnings Summary & Daily Entry Point Trade Alerts - Fundação Cultural do Pará

Oct 28, 2025

Oct 28, 2025

Top chart patterns to watch in Disc Medicine Inc.July 2025 Breakouts & Consistent Profit Focused Trading Strategies - newser.com

Oct 28, 2025

Oct 28, 2025

How Disc Medicine Inc. stock performs in interest rate cycles2025 AllTime Highs & Weekly Top Gainers Trade List - newser.com

Oct 28, 2025

Oct 27, 2025

Disc Medicine’s APOLLO Study: A Potential Game-Changer for EPP and XLP Treatment - TipRanks

Oct 27, 2025

Oct 27, 2025

Disc Medicine’s Promising Phase 2 Study on DISC-3405 for Polycythemia Vera - TipRanks

Oct 27, 2025

Oct 27, 2025

Disc Medicine’s New Study on DISC-3405: A Potential Breakthrough for Sickle Cell Disease - TipRanks

Oct 27, 2025

Oct 27, 2025

What Makes Disc Medicine, Inc. (IRON) a Strong Momentum Stock: Buy Now? - sharewise.com

Oct 27, 2025

Oct 27, 2025

Disc Medicine’s Promising EPP Treatment Study: Key Updates and Market Impact - TipRanks

Oct 27, 2025